PXN and glioblastoma: As a highly expressed central gene in glioblastoma (GBM), paxillin expression is negatively correlated with the overall survival, progression-free survival, and disease-free survival of GBM patients, which can be used as an independent prognostic factor and an independent prognostic biomarker in GBM patients [40,41].